Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement.
Treasury yields tick higher ahead of the first interest rate decision under Fed Chairman Kevin Warsh. Rates are expected to remain unchanged. Investors are curious about how Warsh will change the central bank's communications with the public and its forward guidance.
Stock Market Today: The Dow Jones index wavered Wednesday ahead of the Fed's decision and Fed Chair Warsh's comments. SpaceX stock rallied.
The market has the most to lose if the central bank raises interest rates. Its rally is powered by tech and AI, making it risky, risky, risky.
Micron Technology stock was back on the rise early Wednesday as the memory-chip maker looks to resume its relentless rally. Micron was leading the rebound in premarket trading, rising 3.5%, the second-best performer in the Only Intel was climbing more ahead of the open. When there’s nothing happening Micron stock tends to gain.
US stocks look set for a cautious start on Wednesday as investors await the first Federal Reserve interest rate decision under new chair Kevin Warsh, with the focus less on the immediate policy outcome and more on the route forward. Futures point to a flat open for the Dow Jones and S&P...
TGT, NFG and CAT recently raised dividends as investors navigate inflation, rate-hike concerns and ongoing market uncertainty.
<body><p>STORY: Big pharma is receiving pushback from European capitals on drug pricing. </p><p>So they’re turning to a playbook that brought them success in the UK.</p><p>Making threats to pull investment plans to pressure policymakers. </p><p>The industry notched a win when the British government agreed to increase medicine spending as part of a broader deal to avoid U.S.-imposed tariffs. </p><p>The latest nation to face pressure is Germany, which has been debating legislation to tighten spending on medicines. </p><p>A Reuters European Pharma correspondent Maggie Fick said pressure in the last week has ramped up. </p><p>"The CEO of Pfizer wrote a letter to the German chancellor warning that their future investments in the country may be at risk over these proposed changes to pricing laws."</p><p>Meanwhile, AstraZeneca warned that it may not launch new medicines in Germany if these changes go ahead.</p><p>Earlier in June, Eli Lilly announced it would halve a planned $2.7 billion investment, also citing the proposed legislation. </p><p>This bid to cap costs has centered Germany in a broader tussle between drugmakers and European governments that began several months ago.</p><p>That tension has been sharpened by the impact on Europe of U.S. President Donald Trump's pricing push.</p><p>This aims to tie prescription medicine prices in the lucrative U.S. market to lower prices elsewhere, including in Europe.</p><p>Major drugmakers have struck deals with the White House to lower drug costs in exchange for tariff exemptions, adding to pressure for increasing prices elsewhere.</p></body>
US equity futures were slightly higher pre-bell Wednesday as traders await the Federal Reserve's rat
The Fed is expected to hold rates steady, while SpaceX stock continues its post-IPO climb and chip stocks also advance
Wall Street futures pointed moderately higher pre-bell Wednesday, as oil prices steadied well under
WeRide (NASDAQ:WRD) and Uber Technologies (NYSE:UBER) plan to introduce commercial robotaxi services in the Greater Zurich Region later this year, extending their autonomous mobility partnership in Europe following a recent deployment announcement in Madrid. The service is expected to launch during 2026, pending approval from Switzerland’s Federal Roads Office (FEDRO).
U.S. stock futures rose as further details on a memorandum of understanding between the U.S. and Iran lifted sentiment.
FEATURE Artificial-intelligence stocks were mounting a comeback on Wednesday, having slumped the previous session, as hopes of a peace deal between the U.S. and Iran led investors to pile back into some of the market’s best-loved names.
Investing.com -- President Donald Trump expressed approval of Canada's agreement with China that limits Chinese electric vehicle imports through a quota system with reduced tariffs, Canadian Prime Minister Mark Carney said Wednesday at the Group of Seven leaders summit in Evian, France.
June Nasdaq 100 E-Mini futures (NQM26) are up +0.54% this morning, signaling a rebound from yesterday’s selloff, while investors await the first Federal Reserve rate decision under Kevin Warsh.
Stocks were on track to rise Wednesday after more details about the U.S.-Iran peace deal leaked, bolstering hopes that the two countries are on the brink of reaching an agreement to end the war in the Middle East. Futures tracking the tech-heavy Nasdaq 100 gained 0.5%, while S&P 500 futures added 0.1%. The market looked set for a broader rally on Wednesday after The Wall Street Journal reported that the U.S. would allow Iran to immediately begin selling oil and fuel under the deal to end the war, citing people familiar with the agreement.
And the odds were pretty slim to begin with, leaving investors unsure of what to do next.
Does AI hype have Wall Street ignoring inflation? Trader Talk host Kenny Polcari discusses the growing concerns with NYSE Senior Market Strategist Michael Reinking, and Tuttle Capital Management CEO & CIO, Matthew Tuttle
Bitcoin is trading at approximately $65,829 as Federal Reserve Chair Kevin Warsh steps in to chair his first FOMC meeting. While traders analyzing whether the central bank will hike or hold this Wednesday have priced in a 3.50-3.75% rate hold at a 97.4% probability per the CME FedWatch tool, the true market driver remains Warsh’s impending forward guidance.
Two U.S. senators have requested a federal investigation into Tesla's self-published safety data for its Full Self-Driving system, questioning whether the company has overstated real-world safety performance. Regulators in Sweden and the Netherlands have also accused Tesla of providing misleading information about Full Self-Driving, adding pressure on the company in key European markets. The scrutiny focuses on the accuracy and presentation of data used to support Tesla's autonomy claims,...
(Bloomberg) -- Governments around the world look to be facing lofty borrowing costs for at least the rest of the year, even as the fragile Middle East truce lowers energy prices and curbs inflationary fears.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gain
Stocktwits data showed retail sentiment has improved to ‘bullish’ on SPY and ‘neutral’ on QQQ from ‘bearish’ earlier in the week.
Potential interest rate increases (and downstream effects such as higher bond yields) could mean trouble for the stock market, especially if they coincide with new tariffs.
The Morning Bull - US Market Morning Update Wednesday, Jun, 17 2026 US stock futures are mixed this morning, with S&P 500 contracts slightly softer while Nasdaq 100 futures edge up, as investors weigh a steady US 10 year yield near 4.47% against soft factory data. The 4.47% yield matters because it anchors mortgage costs and business borrowing, so a stable reading suggests no fresh rate shock ahead of the upcoming Federal Reserve meeting. At the same time, US industrial output for May grew...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
